Distillers Hub™ Sign inList your company
Industry news / Markets

Markets · Global

Heineken Internal Assessment Highlights Emerging Risk from Weight-Loss Medications

· 1 min read · Source: Hospitality Ireland

An internal document from Heineken shows increasing corporate concern regarding the expanding adoption of weight-loss drugs. The brewer is assessing how these pharmaceuticals could dampen beverage alcohol consumption patterns globally.

Read the full report at Hospitality Ireland

Summary written by Distillers Hub from the original report. Spotted an error? Tell us.

Share this storyWhatsAppLinkedInXFacebook

More industry news

All news

Buying or selling bulk spirit, equipment or packaging?